Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Eur J Surg Oncol. 2023 Aug 6;49(10):106997. doi: 10.1016/j.ejso.2023.106997

Table 5.

Comparison between baseline characteristics of MILR in cirrhotic patients with and without portal hypertension

Entire unmatched cohort 1:1 PSM (nearest neighbour matching) 1:1 CEM

All (N = 1283) Cirrhosis PHT (N = 310) Cirrhosis NPHT (N = 973) P-value Cirrhosis PHT (N = 227) Cirrhosis NPHT (N = 227) P-value Cirrhosis PHT (N = 116) Cirrhosis NPHT (N = 116) P-value (paired)

Mean age (SD), yrs 63.00 [55.00, 71.00] 64.15 [56.25, 71.00] 63.00 [54.00, 71.00] 0.836 63.00 [55.50, 71.00] 63.00 [55.00, 70.60] 0.658 63.62 [56.00, 69.62] 63.00 [55.00, 70.00] 0.432

Male sex, n (%) 960 (74.8) 218 (70.3) 742 (76.3) 0.043 168 (74.0) 174 (76.7) 0.566 93 (80.2) 93 (80.2) NA

Robotic, n (%) 138 (10.8) 35 (11.3) 103 (10.6) 59 (26.0) 53 (23.3) 23 (19.8) 23 (19.8)
Laparoscopic, n (%) 1145 (89.2) 275 (88.7) 870 (89.4) 0.808 199 (87.7) 201 (88.5) 0.885 113 (97.4) 113 (97.4) NA

Previous abdominal surgery, n (%) 210 (16.9) 63 (20.3) 147 (15.8) 0.079 46 (20.3) 54 (23.8) 0.403 13 (11.2) 13 (11.2) NA

Childs A, n (%) 1144 (89.3) 253 (81.6) 891 (91.8) 193 (85.0) 190 (83.7) 111 (95.7) 111 (95.7)
Childs B, n (%) 137 (10.7) 57 (18.4) 80 (8.2) <0.001 34 (15.0) 37 (16.3) 0.755 5 (4.3) 5 (4.3) NA

Year of surgery, n (%)
2004–2009 19 (1.5) 5 (1.6) 14 (1.4) 3 (1.3) 3 (1.3)
2010–2015 304 (23.7) 68 (21.9) 236 (24.3) 44 (19.4) 46 (20.3) 13 (11.2) 13 (11.2)
2016–2021 960 (74.8) 237 (76.5) 723 (74.3) 0.668 180 (79.3) 178 (78.4) 0.750 103 (88.8) 103 (88.8) NA

ASA score, n (%)
 1/2 884 (68.9) 187 (60.3) 697 (71.6) 152 (67.0) 143 (63.0) 79 (68.1) 79 (68.1)
 3/4 399 (31.1) 123 (39.7) 276 (28.4) <0.001 75 (33.0) 84 (37.0) 0.391 37 (31.9) 37 (31.9) NA

Tumor type, n (%)
 HCC 1222 (95.2) 300 (96.8) 922 (94.8) 221 (97.4) 220 (96.9) 116 (100.0) 116 (100.0)
 ICC/cholangiohepatoma 61 (4.8) 10 (3.2) 51 (5.2) 0.194 6 (2.6) 7 (3.1) 1.000 0 (0.0) 0 (0.0) NA

Median tumor size, mm (IQR) 25.00 [19.00, 40.00] 26.00 [20.00, 40.00] 25.00 [18.00, 40.00] 0.664 26.00 [20.00, 40.00] 26.00 [20.00, 35.00] 0.940 25.00 [20.00, 32.00] 25.00 [20.00, 31.25] 0.802

Multiple tumors, n (%) 124 (9.7) 28 (9.0) 96 (9.9) 0.747 17 (7.5) 18 (7.9) 1.000 0 (0.0) 0 (0.0) NA

Wedge/partial liver resection, n (%) 790 (61.6) 194 (62.6) 596 (61.3) 140 (61.7) 138 (60.8) 82 (70.7) 82 (70.7)
Segmentectomy, n (%) 493 (38.4) 116 (37.4) 377 (38.7) 0.725 87 (38.3) 89 (39.2) 0.918 34 (29.3) 34 (29.3) NA

Concomitant minor surgery excluding cholecystectomy, n (%) 49 (3.8) 10 (3.2) 39 (4.0) 0.649 9 (4.0) 9 (4.0) 1.000 0 (0.0) 0 (0.0) NA

Hilar lymph node dissection, n (%) 11 (0.9) 2 (0.6) 9 (0.9) 1.000 2 (0.9) 1 (0.4) 1.000 0 (0.0) 0 (0.0) NA

Median Iwate difficulty score, [IQR] (range) 6.00 [5.00, 8.00] (4, 11) 6.00 [5.00, 9.00] (4, 11) 6.00 [5.00, 8.00] (4, 11) 0.904 6.00 [5.00, 9.00] (4, 11) 6.00 [5.00, 9.00] (4, 11) 0.990 6.00 [5.00, 8.00] (4, 10) 6.00 [5.00, 8.00] (4, 10) NA

Iwate difficulty, n (%)
 Low 1 (0.1) 0 (0.0) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Intermediate 724 (56.4) 166 (53.5) 558 (57.3) 121 (53.3) 121 (53.3) 79 (68.1) 79 (68.1)
 High 466 (36.3) 116 (37.4) 350 (36.0) 87 (38.3) 85 (37.4) 36 (31.0) 36 (31.0)
 Expert 92 (7.2) 28 (9.0) 64 (6.6) 0.385 19 (8.4) 21 (9.3) 0.161 1 (0.9) 1 (0.9) NA

Footnotes:

MILR indicates minimally invasive liver resection; PSM, propensity score matching; CEM, coarsened exact matching; SD, standard deviation; PHY, portal hypertension; NPHT no portal hypertension NA, not available; ASA, American Society of Anesthesiologists; HCC hepatocellular carcinoma; ICC intrahepatic cholangiocarcinoma; IQR, interquartile range